Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].
Wang J, Sun Y, Liu Y, Yu Q, Zhang Y, Li K, Zhu Y, Zhou Q, Hou M, Guan Z, Li W, Zhuang W, Wang D, Liang H, Qin F, Lu H, Liu X, Sun H, Zhang Y, Wang J, Luo S, Yang R, Tu Y, Wang X, Song S, Zhou J, You L, Wang J, Yao C. Wang J, et al. Among authors: yao c. Zhongguo Fei Ai Za Zhi. 2005 Aug 20;8(4):283-90. doi: 10.3779/j.issn.1009-3419.2005.04.07. Zhongguo Fei Ai Za Zhi. 2005. PMID: 21108883 Free article. Chinese.
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer.
Sun Y, Wang JW, Liu YY, Yu QT, Zhang YP, Li K, Xu LY, Luo SX, Qin FZ, Chen ZT, Liu WC, Zhou QH, Chen Q, Nan KJ, Liu XQ, Liu W, Liang HJ, Lu HS, Wang XW, Wang JJ, Song SP, Tu YR, Zhou JM, Li WL, Yao C; Endostar Phase III NSCLC Study Group. Sun Y, et al. Among authors: yao c. Thorac Cancer. 2013 Nov;4(4):440-448. doi: 10.1111/1759-7714.12050. Thorac Cancer. 2013. PMID: 28920215 Free article.
Tenecteplase versus alteplase in treatment of acute ST-segment elevation myocardial infarction: A randomized non-inferiority trial.
Zhao X, Zhu Y, Zhang Z, Tao G, Xu H, Cheng G, Gao W, Ma L, Qi L, Yan X, Wang H, Xia Q, Yang Y, Li W, Rong J, Wang L, Ding Y, Guo Q, Dang W, Yao C, Yang Q, Gao R, Wu Y, Qiao S. Zhao X, et al. Among authors: yao c. Chin Med J (Engl). 2024 Feb 5;137(3):312-319. doi: 10.1097/CM9.0000000000002731. Epub 2023 Jun 2. Chin Med J (Engl). 2024. PMID: 37265385 Free PMC article. Clinical Trial.
Effectiveness and Safety of Transdermal Buprenorphine Versus Sustained-release Tramadol in Patients With Moderate to Severe Musculoskeletal Pain: An 8-Week, Randomized, Double-Blind, Double-Dummy, Multicenter, Active-controlled, Noninferiority Study.
Leng X, Li Z, Lv H, Zheng Y, Liu Y, Dai K, Yao C, Yan X, Zeng X. Leng X, et al. Among authors: yao c. Clin J Pain. 2015 Jul;31(7):612-20. doi: 10.1097/AJP.0000000000000144. Clin J Pain. 2015. PMID: 25503600 Clinical Trial.
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study.
Zheng Y, Cai GY, He LQ, Lin HL, Cheng XH, Wang NS, Jian GH, Liu XS, Liu YN, Ni ZH, Fang JA, Ding HL, Guo W, He YN, Wang LH, Wang YP, Yang HT, Ye ZM, Yu RH, Zhao LJ, Zhou WH, Li WG, Mao HJ, Zhan YL, Hu Z, Yao C, Wei RB, Chen XM. Zheng Y, et al. Among authors: yao c. Chin Med J (Engl). 2017 Oct 20;130(20):2402-2409. doi: 10.4103/0366-6999.216407. Chin Med J (Engl). 2017. PMID: 29052559 Free PMC article. Clinical Trial.
Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study.
Zheng Y, Wang NS, Liu YN, He LQ, Jian GH, Liu XS, Ni ZH, Cheng XH, Lin HL, Zhou WH, Wang YP, Fang JA, He YN, Yang HT, Zhao LJ, Ding HL, Wang LH, Yu RH, Li WG, Ye ZM, Guo W, Zhan YL, Mao HJ, Hu Z, Yao C, Cai GY, Chen XM. Zheng Y, et al. Among authors: yao c. Chin J Integr Med. 2019 Mar;25(3):168-174. doi: 10.1007/s11655-018-2998-y. Epub 2018 Nov 22. Chin J Integr Med. 2019. PMID: 30467695 Clinical Trial.
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II-IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial.
Yang D, Hou X, Qian K, Li Y, Hu L, Li L, Han M, Yao C, Liu D. Yang D, et al. Among authors: yao c. Trials. 2023 May 3;24(1):306. doi: 10.1186/s13063-023-07305-0. Trials. 2023. PMID: 37138332 Free PMC article.
5,081 results